Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
/in Dendritic Cells, International Publications /von 2015-05-20 / Front Immunol 2015;6:243Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
/in Breast Cancer, Hyperthermia, International Publications /von 2015-05-19 / Radiother Oncol 2015 Nov;117(2):217-22Advances in the understanding of cancer immunotherapy
/in Dendritic Cells, International Publications /von 2015-05-18 / BJU Int. 2015 Sep;116(3):321-9Vaccine immunotherapy in lung cancer: Clinical experience and future directions
/in International Publications, NSCLC, SCLC /von 2015-05-16 / Pharmacol. Ther. 2015 Sep;153:1-9Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
/in Hyperthermia, International Publications /von 2015-05-15 / Int J Hyperthermia 2015;31(6):609-14IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
/in International Publications, Newcastle Disease Virus /von 2015-05-07 / Cell Death Dis 2015 May;6:e1758Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors
/in Dendritic Cells, International Publications /von 2015-05-01 / J. Immunother. 2015 May;38(4):155-64Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway
/in Hypernephroma, International Publications, Newcastle Disease Virus /von 2015-05-01 / Cell Oncol (Dordr) 2015 Aug;38(4):279-88Hyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience
/in Breast Cancer, Hyperthermia, International Publications /von 2015-04-23 / Swiss Med Wkly 2015;145:w14133
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de